» Articles » PMID: 39245738

Causal Inference of the Effect of Plasma Proteins on the Incidence of Oral Cancer: Two-sample Mendelian Randomization

Overview
Journal BMC Oral Health
Publisher Biomed Central
Specialty Dentistry
Date 2024 Sep 8
PMID 39245738
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: This study is aimed to investigate the causal relationship between plasma proteins and oral cancer risk using two-sample MR (Mendelian randomization).

Methods: Summary-level GWAS (genome-wide association study) data on plasma protein levels (4,907 proteins) and oral cancer (6,034 cases, 6,585 controls) of European ancestry were utilized. SNPs (single nucleotide polymorphisms) associated with proteins at genome-wide significance were selected as instrumental variables. Multiple MR methods including IVW (inverse-variance weighted), MR-Egger, weighted median, simple mode and weighted mode were applied to estimate causal effects. Sensitivity analyses were conducted.

Results: Eight plasma proteins (CCDC167, MID2, NDRG4, PEAR1, PIAS4, RCAN1, SAMHD1 and TNMD) were identified to have significant causal associations with oral cancer risk. NDRG4, RCAN1, SAMHD1 and TNMD were associated with increased oral cancer risk while PEAR1 was associated with decreased risk. The causal estimates were consistent across different methods. Sensitivity analyses indicated the results were robust without significant heterogeneity or horizontal pleiotropy. Multivariable MR adjusting for smoking, alcohol intake and periodontal disease showed CCDC167, MID2, NDRG4, PEAR1, PIAS4 and SAMHD1 still had direct effects on oral cancer.

Conclusion: This two-sample MR study provides evidence for potentially causal effects of several plasma proteins on oral cancer risk. The identified proteins may serve as biomarkers and shed light on biological mechanisms underlying oral carcinogenesis. Further research is warranted to validate and extend these findings.

Citing Articles

Plasma proteins mediate the effects of the gut microbiota on the development of head and neck cancer: a two-sample and mediated Mendelian randomized study.

Rao J, Zhang W, Zha C, Zhang M, Xing Y, Wang Z Discov Oncol. 2025; 16(1):202.

PMID: 39969766 PMC: 11839960. DOI: 10.1007/s12672-025-01983-9.

References
1.
Buranapraditkun S, Mahattanasakul P, Diloktaweewattana A, Bhummaphan N, Siriwattanakankul C, Bin-Alee F . Immune-associated plasma proteins in oral and oropharyngeal cancer patients. Heliyon. 2022; 8(9):e10753. PMC: 9525905. DOI: 10.1016/j.heliyon.2022.e10753. View

2.
Wang J, Lu F, Shen X, Wu Y, Zhao L . SAMHD1 is down regulated in lung cancer by methylation and inhibits tumor cell proliferation. Biochem Biophys Res Commun. 2014; 455(3-4):229-33. DOI: 10.1016/j.bbrc.2014.10.153. View

3.
Gormley M, Dudding T, Sanderson E, Martin R, Thomas S, Tyrrell J . A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020; 11(1):6071. PMC: 7695733. DOI: 10.1038/s41467-020-19822-6. View

4.
Ferkingstad E, Sulem P, Atlason B, Sveinbjornsson G, Magnusson M, Styrmisdottir E . Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021; 53(12):1712-1721. DOI: 10.1038/s41588-021-00978-w. View

5.
Bottomly D, Long N, Schultz A, Kurtz S, Tognon C, Johnson K . Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell. 2022; 40(8):850-864.e9. PMC: 9378589. DOI: 10.1016/j.ccell.2022.07.002. View